Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

924 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II trial of blood-brain barrier permeable peptide-paclitaxel conjugate ANG1005 in patients with recurrent high-grade glioma.
Dmello C, Brenner A, Piccioni D, Wen PY, Drappatz J, Mrugala M, Lewis LD, Schiff D, Fadul CE, Chamberlain M, Kesari S, Ahluwalia M, Ghosh D, Sonabend AM, Kumthekar P. Dmello C, et al. Among authors: chamberlain m. Neurooncol Adv. 2024 Dec 14;6(1):vdae186. doi: 10.1093/noajnl/vdae186. eCollection 2024 Jan-Dec. Neurooncol Adv. 2024. PMID: 39713041 Free PMC article.
Phase 1b/2 study of orally administered pexidartinib in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma.
Mendez JS, Cohen AL, Eckenstein M, Jensen RL, Burt LM, Salzman KL, Chamberlain M, Hsu HH, Hutchinson M, Iwamoto F, Ligon KL, Mrugala MM, Pelayo M, Plotkin SR, Puduvalli VK, Raizer J, Reardon DA, Sterba M, Walbert T, West BL, Wong ET, Zhang C, Colman H. Mendez JS, et al. Among authors: chamberlain m. Neurooncol Adv. 2024 Nov 22;6(1):vdae202. doi: 10.1093/noajnl/vdae202. eCollection 2024 Jan-Dec. Neurooncol Adv. 2024. PMID: 39734810 Free PMC article.
A phase 1b open-label study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of py314 in combination with pembrolizumab in patients with advanced renal cell carcinoma.
Beckermann KE, Patnaik A, Winer I, Tan W, Bashir B, Kyriakopoulos CE, Sweis RF, Chamberlain M, Rini BI. Beckermann KE, et al. Among authors: chamberlain m. Invest New Drugs. 2024 Apr;42(2):179-184. doi: 10.1007/s10637-024-01419-1. Epub 2024 Feb 19. Invest New Drugs. 2024. PMID: 38372949 Clinical Trial.
Myeloid targeting antibodies PY159 and PY314 for platinum-resistant ovarian cancer.
Yeku OO, Barve M, Tan WW, Wang J, Patnaik A, LoRusso P, Richardson DL, Naqash AR, Lynam SK, Fu S, Gordon M, Hubbard J, Kummar S, Kyriakopoulos C, Dowlati A, Chamberlain M, Winer I. Yeku OO, et al. Among authors: chamberlain m. J Immunother Cancer. 2025 Mar 13;13(3):e010959. doi: 10.1136/jitc-2024-010959. J Immunother Cancer. 2025. PMID: 40081941 Free PMC article.
Gene model for the ortholog of eIF4E1 in Drosophila ananassae.
Chamberlain M, Christie A, Girard J, Shaver HM, Long LJ, Youngblom JJ, Rele CP, Reed LK. Chamberlain M, et al. MicroPubl Biol. 2025 Jan 29;2025:10.17912/micropub.biology.001026. doi: 10.17912/micropub.biology.001026. eCollection 2025. MicroPubl Biol. 2025. PMID: 39950091 Free PMC article.
Intrinsic and environmental drivers of pairwise cohesion in wild Canis social groups.
Benson JF, Keiter DA, Mahoney PJ, Allen BL, Allen L, Álvares F, Anderson ML, Barber-Meyer SM, Barocas A, Beasley JC, Behrendorff L, Belant JL, Beyer DE Jr, Boitani L, Borg BL, Boutin S, Boydston EE, Brown JL, Bump JK, Cepek JD, Chamberlain MJ, Chenaux-Ibrahim YM, Cherry SG, Ćirović D, Ciucci P, Cluff HD, Cooper SM, Crooks KR, Dupont DLJ, Fisher RN, Fortin D, Gable TD, García E, Geffen E, Gehrt SD, Gillingham M, Heard DC, Hebblewhite M, Hinton JW, Homkes AT, Howden CG, Huber D, Jackson PJ, Joly K, Kelly A, Kelly MJ, Kingdon KA, Kulkarni A, Kusak J, Kuzyk GW, Lake BC, Llaneza L, López-Bao JV, MacNulty DR, McLaren AAD, McLoughlin PD, Merrill EH, Mills KJ, Mitchell N, Moore SA, Mumma MA, Murray MH, Musiani M, Nakamura M, Neilson EW, Neufeld LM, Newsome TM, Oakleaf JK, Palacios V, Perdicas MM, Perry T, Petroelje TR, Piper CB, Prokopenko CM, Prugh LR, Riley SPD, Rio-Maior H, Roffler GH, Rollins D, Sand H, Schmiegelow FKA, Seip DR, Sorum MS, St Clair CC, Steenweg R, Strohbach MW, Tatler J, Thaker M, Thompson CA, Turner JW, Vanak AT, Vander Wal E, Wabakken P, Walter SE, Webster SC, Wheeldon TJ, Wikenros C, Windels SK, Young JK, Zabihi-Seissan S, Zimmermann B, Patterson BR. Benson JF, et al. Among authors: chamberlain mj. Ecology. 2025 Jan;106(1):e4492. doi: 10.1002/ecy.4492. Epub 2024 Dec 12. Ecology. 2025. PMID: 39663892 Free PMC article.
Climate refugia in the Great Barrier Reef may endure into the future.
Sun C, Steinberg C, Klein Salas E, Mellin C, Babcock RC, Schiller A, Cantin NE, Stella JS, Baird ME, Condie SA, Hobday AJ, Herzfeld M, Jones NL, Zhang X, Chamberlain MA, Fiedler R, Green C, Steven ADL. Sun C, et al. Among authors: chamberlain ma. Sci Adv. 2024 Nov 29;10(48):eado6884. doi: 10.1126/sciadv.ado6884. Epub 2024 Nov 29. Sci Adv. 2024. PMID: 39612332 Free PMC article.
924 results